Additional file 1. Table S1. Presenting clinical features of individuals found not to have clinically significant variants
Table S2. Recessive variants shared by a common gene in at least two different trios. Possibly patho...
Table S4. Significant canonical pathways represented by unique variants in âaffectedâ subjects. ...
Genetic tests performed during the diagnostic work-up of the study participants. (DOC 55 kb
Additional file 2. Table S2. chILDRANZ gene panel (see PanelApp Australia Childhood Interstitial Lun...
The information of Sanger sequencing validation for seven exonic variants of TACC2
Run Metrics for family trio. Read depth values exclude the following: reads of low quality, reads th...
Figure S1. CADD scoring of prioritized variants versus other variants in the selected genes. (PDF 71...
Table S3. Variants of unknown significance (class 3) and variants in TRAF3 identified in 17 patients...
Annotated variants for the 81 COPD candidate genes. Whole exome sequencing variants identified in th...
COPD candidate genes prioritized by the VAAST analysis. Results from different VAAST run settings (T...
Table S9. Significant canonical pathways represented by unique variants in âaffectedâ subjects f...
Table S3. Significant canonical pathways represented by common variants associated with BPD. (DOCX 3...
Table S5. Significant canonical pathways represented by unique variants in âunaffectedâ subjects...
Additional file 1: Table S1. Incidental genetic findings identified across four study sites conducti...
Overview of the number of variants detected at each filter step for each patient. (DOC 128 kb
Table S2. Recessive variants shared by a common gene in at least two different trios. Possibly patho...
Table S4. Significant canonical pathways represented by unique variants in âaffectedâ subjects. ...
Genetic tests performed during the diagnostic work-up of the study participants. (DOC 55 kb
Additional file 2. Table S2. chILDRANZ gene panel (see PanelApp Australia Childhood Interstitial Lun...
The information of Sanger sequencing validation for seven exonic variants of TACC2
Run Metrics for family trio. Read depth values exclude the following: reads of low quality, reads th...
Figure S1. CADD scoring of prioritized variants versus other variants in the selected genes. (PDF 71...
Table S3. Variants of unknown significance (class 3) and variants in TRAF3 identified in 17 patients...
Annotated variants for the 81 COPD candidate genes. Whole exome sequencing variants identified in th...
COPD candidate genes prioritized by the VAAST analysis. Results from different VAAST run settings (T...
Table S9. Significant canonical pathways represented by unique variants in âaffectedâ subjects f...
Table S3. Significant canonical pathways represented by common variants associated with BPD. (DOCX 3...
Table S5. Significant canonical pathways represented by unique variants in âunaffectedâ subjects...
Additional file 1: Table S1. Incidental genetic findings identified across four study sites conducti...
Overview of the number of variants detected at each filter step for each patient. (DOC 128 kb
Table S2. Recessive variants shared by a common gene in at least two different trios. Possibly patho...
Table S4. Significant canonical pathways represented by unique variants in âaffectedâ subjects. ...
Genetic tests performed during the diagnostic work-up of the study participants. (DOC 55 kb